Richard Gonzalez, AbbVie CEO (Chris Kleponis/picture-alliance/dpa/AP Images)
April 30, 2021 09:45 AM EDT
Pharma

House com­mit­tee to grill Ab­b­Vie CEO next month on sup­press­ing Hu­mi­ra com­pe­ti­tion

Zachary Brennan

Senior Editor

Ab­b­Vie CEO Richard Gon­za­lez will be in the hot seat on May 18, again de­fend­ing the com­pa­ny’s mam­moth block­buster drug Hu­mi­ra be­fore the House Over­sight …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

Ther­mo Fish­er buck­les up for US-Chi­na trade war, bud­gets $2B to ease im­pact

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times